Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism

Ardestani, Amin; Lupse, Blaz; Maedler, Kathrin

Abstract

The evolutionarily conserved Hippo pathway is a key regulator of organ size and tissue homeostasis. Its dysregulation is linked to multiple pathological disorders. In addition to regulating development and growth, recent studies show that Hippo pathway components such as MST1/2 and LATS1/2 kinases, as well as YAP/TAZ transcriptional coactivators, are regulated by metabolic pathways and that the Hippo pathway controls metabolic processes at the cellular and organismal levels in physiological and metabolic disease states such as obesity, type 2 diabetes (T2D), nonalcoholic fatty liver disease (NAFLD), cardiovascular disorders, and cancer. In this review we summarize the connection between key Hippo components and metabolism, and how this interplay regulates cellular metabolism and metabolic pathways. The emerging function of Hippo in the regulation of metabolic homeostasis under physiological and pathological conditions is highlighted.

Citation

Ardestani, A., Lupse, B., & Maedler, K. (2018). Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism. Trends in Endocrinology & Metabolism, 29(7), 492-509. https://doi.org/10.1016/j.tem.2018.04.006

• Journal Article Type: Review
• Online Publication Date: May 5, 2018
• Publication Date: Jul 1, 2018
• Deposit Date: Jan 4, 2024
• Journal: Trends in Endocrinology and Metabolism
• Print ISSN: 1043-2760
• Electronic ISSN: 1879-3061
• Publisher: Cell Press
• Peer Reviewed: Peer Reviewed
• Volume: 29
• Issue: 7
• Pages: 492-509
• DOI: https://doi.org/10.1016/j.tem.2018.04.006
• Public URL: https://hull-repository.worktribe.com/output/4461627